Applying a Computer-based Warfarin Management System at a Large Tertiary Cardiovascular Center in Iran

Author:

Barati Somayyeh1,Mohammadpour Mohammad Mehdi2,Sadrameli Mohammad Ali1,Hosseini Saeed3,Maleki Majid1,Golpira Reza1,Bakhshandeh Hooman1,Kyavar Majid1,Moosavi Jamal1,Mohebbi Bahram1,Talasaz Azita H.4,Barco Stefano56,Klok Frederikus A.67,Sadeghipour Parham1

Affiliation:

1. From the Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran

2. School of Technology, SRH Berlin University of Applied Science, Berlin, Germany

3. Heart Valve Diseases Research Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran

4. Tehran Heart Center, Tehran University of Medical Sciences, Tehran Iran

5. Department of Angiology, University Hospital Zurich, Zurich, Switzerland

6. Center for Thrombosis and Hemostasis, Johannes Gutenberg University Mainz, Mainz, Germany

7. Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands.

Abstract

Background: Regarding adjustments to warfarin dosage, numerous studies have shown that computerized methods are superior to those based on personal experience. Objectives: To report the efficacy of a computer-based warfarin management system (WMS) in the Iranian population. Methods: By utilizing the existing dosing algorithms and obtaining expert opinions, we developed a computer-based WMS at a large tertiary cardiovascular center. The time in therapeutic range and the number of international normalized ratio (INR) tests of clinic patients were compared before and after the implementation of WMS. Results: Overall, 803 patients with 5407 INR tests were included in the before phase and 679 patients with 4189 INR tests in the after phase. The mean time in therapeutic range was 57.3% before and 59% after WMS implementation [mean difference, 1.64; 95% confidence interval (CI), −1.12–4.40]. In the before phase, the mean number of INR tests was 6.7, which dropped to 6.1 tests in the after phase (mean difference, −0.61; 95% CI, −0.97 to −0.24). Only 54.5% of the warfarin dosing prescriptions were consistent with the dosing recommendations of the WMS, and adherence to the WMS was poorest in the highest INR target range. Conclusions: For the first time in Iran, we demonstrated that a computerized system was as effective as a traditional experience-based method to monitor INR in VKA-anticoagulated patients. Furthermore, it could reduce both the number of INR tests and that of visits.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference27 articles.

1. 2021 ESC/EACTS guidelines for the management of valvular heart disease.;Vahanian;Eur Heart J,2022

2. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College Of Cardiology/American Heart Association Joint Committee On Clinical Practice Guidelines.;Otto;Circulation,2021

3. Old and new oral anticoagulants: food, herbal medicines and drug interactions.;Di Minno;Blood Rev,2017

4. Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range.;Schmitt;J Thromb Thrombolysis,2003

5. Computer assisted management of warfarin treatment.;Wilson;Br Med J (Clin Res Ed),1984

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3